FDA picks critic of COVID boosters to be new top vaccines official
CBSN
The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters.
Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation and Research at the FDA and played a key role in launching Operation Warp Speed – the Trump administration's effort to speed up the development of vaccines – during the COVID-19 pandemic. The center has been operating with an acting director since Marks left the FDA in March.
"Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward," FDA Commissioner Dr. Martin Makary posted on X on Tuesday.
